NEW MEYER CANCER CENTER CLINICAL RESEARCH LEADERSHIP TEAM
Wednesday, October 16, 2024
The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork- Presbyterian Hospital is pleased to announce a new cancer clinical research leadership team:
- Vered Stearns, MD is Associate Director for Clinical Research and charged with strengthening MCC clinical research efforts across all oncology-related disciplines at WCM and aligning initiatives and resources across the hospital and college.
- Paul Chapman, MD is Medical Director for the Cancer Clinical Trials Office (CCTO) and charged with providing medical direction, growth strategy, and oversight of quality for research services provided by the CCTO at all MCC clinical research sites.
- Anna Pavlick, DO, MBA is Medical Director for the Oncology Service Line and charged with oversight of the oncology clinical enterprise and ensuring that clinical research is a care option for all WCM cancer patients.
The Meyer Cancer Center Cancer Clinical Trials Office (CCTO) is the enterprise-wide authority on cancer clinical research processes. It provides core support for all oncology clinical research programs at three campuses located in Manhattan, Brooklyn, and Queens. Read More about MCC Cancer Clinical Trials
